Skip to main content
SpringerLink
Log in

Management of anemia with intravenous methoxy polyethylene glycol–epoetin beta in patients on dialysis

  • Practice Point
  • Published:

From Nature Clinical Practice Nephrology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Drüeke TB et al. (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355: 2071–2084

    Article  Google Scholar 

  2. Singh AK et al. (2006) Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355: 2085–2098

    Article  CAS  Google Scholar 

  3. Foley RN et al. (2000) Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int 58: 1325–1335

    Article  CAS  Google Scholar 

  4. Levin A (2007) Understanding recent haemoglobin trials in CKD: methods and lesson learned from CREATE and CHOIR. Nephrol Dial Transplant 22: 309–312

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice. The author of the commentary is in no way related to the author of the original article.

Author information

Author notes

  1. University of British Columbia, Division of Nephrology, St Paul's Hospital, 1081 Burrard Street, room 6010, Vancouver, BC V6Z 1Y6, Canada alevin@providencehealth.bc.ca

Authors and Affiliations

  1. A Levin is a Professor of Medicine in the Division of Nephrology at the University of British Columbia, Vancouver, BC, Canada.,

    Adeera Levin

Authors
  1. Adeera Levin
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author has served on speakers bureaux for Amgen, Janssen-Cilag, Ortho Biotech and Roche; has received grant/research support from Janssen-Cilag, Ortho Biotech and Roche; and has served as a consultant for Ortho Biotech and Roche.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levin, A. Management of anemia with intravenous methoxy polyethylene glycol–epoetin beta in patients on dialysis. Nat Rev Nephrol 4, 186–187 (2008). https://doi.org/10.1038/ncpneph0761

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0761

  • Springer Nature Limited

Search

Navigation